Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 7.72298388 |
2 | central nervous system myelination (GO:0022010) | 7.72298388 |
3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.04594356 |
4 | sodium ion export (GO:0071436) | 4.79616857 |
5 | ensheathment of neurons (GO:0007272) | 4.45790068 |
6 | axon ensheathment (GO:0008366) | 4.45790068 |
7 | myelination (GO:0042552) | 4.44299495 |
8 | fatty acid elongation (GO:0030497) | 4.39792454 |
9 | neuronal action potential propagation (GO:0019227) | 4.27543412 |
10 | synaptic vesicle maturation (GO:0016188) | 4.12596755 |
11 | establishment of mitochondrion localization (GO:0051654) | 4.09784254 |
12 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.07994539 |
13 | neuron cell-cell adhesion (GO:0007158) | 3.82495569 |
14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.74722563 |
15 | apical protein localization (GO:0045176) | 3.74371293 |
16 | negative regulation of neurotransmitter transport (GO:0051589) | 3.66915103 |
17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.65068947 |
18 | synaptic vesicle exocytosis (GO:0016079) | 3.57407279 |
19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.53177958 |
20 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.51496326 |
21 | presynaptic membrane organization (GO:0097090) | 3.44169695 |
22 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.40310417 |
23 | neurofilament cytoskeleton organization (GO:0060052) | 3.29762217 |
24 | glutamate secretion (GO:0014047) | 3.28936061 |
25 | adult walking behavior (GO:0007628) | 3.27974472 |
26 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.24216085 |
27 | asymmetric protein localization (GO:0008105) | 3.22673369 |
28 | regulation of mononuclear cell migration (GO:0071675) | 3.20227939 |
29 | glycine transport (GO:0015816) | 3.18521337 |
30 | amino acid import (GO:0043090) | 3.16117945 |
31 | cell communication by electrical coupling (GO:0010644) | 3.15721155 |
32 | presynaptic membrane assembly (GO:0097105) | 3.13437171 |
33 | proline transport (GO:0015824) | 3.07638781 |
34 | L-amino acid import (GO:0043092) | 3.06418082 |
35 | neuromuscular process controlling posture (GO:0050884) | 3.05576373 |
36 | transmission of nerve impulse (GO:0019226) | 3.05512796 |
37 | negative regulation of protein localization to cell surface (GO:2000009) | 3.05222488 |
38 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.03770633 |
39 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.03770633 |
40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03497732 |
41 | neuron recognition (GO:0008038) | 3.01272422 |
42 | response to methylmercury (GO:0051597) | 2.96643236 |
43 | positive regulation of neurotransmitter transport (GO:0051590) | 2.94599177 |
44 | regulation of collateral sprouting (GO:0048670) | 2.94169654 |
45 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.93265360 |
46 | oligodendrocyte differentiation (GO:0048709) | 2.92112120 |
47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.91587094 |
48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.90754347 |
49 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.89728301 |
50 | eye photoreceptor cell differentiation (GO:0001754) | 2.88924372 |
51 | photoreceptor cell differentiation (GO:0046530) | 2.88924372 |
52 | regulation of synaptic vesicle transport (GO:1902803) | 2.88877966 |
53 | neuronal ion channel clustering (GO:0045161) | 2.85738995 |
54 | cellular potassium ion homeostasis (GO:0030007) | 2.85027108 |
55 | cellular sodium ion homeostasis (GO:0006883) | 2.84318390 |
56 | regulation of ARF protein signal transduction (GO:0032012) | 2.84174236 |
57 | positive regulation of potassium ion transport (GO:0043268) | 2.83977678 |
58 | protein localization to endosome (GO:0036010) | 2.83709264 |
59 | regulation of neurotransmitter secretion (GO:0046928) | 2.81483057 |
60 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.80120206 |
61 | axonal fasciculation (GO:0007413) | 2.79064756 |
62 | vocalization behavior (GO:0071625) | 2.77961510 |
63 | protein localization to synapse (GO:0035418) | 2.77381268 |
64 | negative regulation of axonogenesis (GO:0050771) | 2.77333708 |
65 | detection of temperature stimulus (GO:0016048) | 2.76158360 |
66 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.74385739 |
67 | organelle transport along microtubule (GO:0072384) | 2.73806849 |
68 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.72647984 |
69 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.72458975 |
70 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.72232276 |
71 | dendritic spine morphogenesis (GO:0060997) | 2.71649959 |
72 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.69671374 |
73 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.69018522 |
74 | axon development (GO:0061564) | 2.68928191 |
75 | mating behavior (GO:0007617) | 2.65901279 |
76 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.65675206 |
77 | substantia nigra development (GO:0021762) | 2.65353172 |
78 | locomotory exploration behavior (GO:0035641) | 2.65083887 |
79 | protein palmitoylation (GO:0018345) | 2.64907889 |
80 | gamma-aminobutyric acid transport (GO:0015812) | 2.63967649 |
81 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.63398408 |
82 | dendrite morphogenesis (GO:0048813) | 2.63119325 |
83 | response to redox state (GO:0051775) | 2.62741836 |
84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.62142738 |
85 | mitochondrion transport along microtubule (GO:0047497) | 2.61411868 |
86 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.61411868 |
87 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61184717 |
88 | regulation of synapse structural plasticity (GO:0051823) | 2.60826876 |
89 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.60711320 |
90 | potassium ion homeostasis (GO:0055075) | 2.59620187 |
91 | neurotransmitter secretion (GO:0007269) | 2.59319103 |
92 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.58921612 |
93 | neuron remodeling (GO:0016322) | 2.58907851 |
94 | nerve growth factor signaling pathway (GO:0038180) | 2.58674648 |
95 | layer formation in cerebral cortex (GO:0021819) | 2.58414965 |
96 | adenosine receptor signaling pathway (GO:0001973) | 2.57715614 |
97 | regulation of synaptic plasticity (GO:0048167) | 2.57470571 |
98 | astrocyte development (GO:0014002) | 2.56847098 |
99 | negative regulation of JUN kinase activity (GO:0043508) | 2.56201842 |
100 | exploration behavior (GO:0035640) | 2.55987001 |
101 | neuron-neuron synaptic transmission (GO:0007270) | 2.54902482 |
102 | glycerophospholipid catabolic process (GO:0046475) | 2.54773825 |
103 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.54049990 |
104 | glycosphingolipid catabolic process (GO:0046479) | 2.53892729 |
105 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.52983290 |
106 | neurotransmitter transport (GO:0006836) | 2.52288699 |
107 | axon cargo transport (GO:0008088) | 2.52257964 |
108 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.52253708 |
109 | * myelin maintenance (GO:0043217) | 2.52088122 |
110 | membrane hyperpolarization (GO:0060081) | 2.51888405 |
111 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.51816145 |
112 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.51762184 |
113 | vesicle transport along microtubule (GO:0047496) | 2.51536691 |
114 | regulation of macrophage chemotaxis (GO:0010758) | 2.50661069 |
115 | cholesterol biosynthetic process (GO:0006695) | 2.50536659 |
116 | adult locomotory behavior (GO:0008344) | 2.50410123 |
117 | synaptic transmission, glutamatergic (GO:0035249) | 2.49612847 |
118 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.49286171 |
119 | potassium ion import (GO:0010107) | 2.48591930 |
120 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.46952031 |
121 | macrophage activation involved in immune response (GO:0002281) | 2.46942766 |
122 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.46519658 |
123 | neurotransmitter uptake (GO:0001504) | 2.45855622 |
124 | cell migration in hindbrain (GO:0021535) | 2.45260160 |
125 | regulation of neurotransmitter transport (GO:0051588) | 2.44188406 |
126 | cerebellar granule cell differentiation (GO:0021707) | 2.44040851 |
127 | regulation of early endosome to late endosome transport (GO:2000641) | 2.42748048 |
128 | response to parathyroid hormone (GO:0071107) | 2.42524006 |
129 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.42135940 |
130 | glutamate receptor signaling pathway (GO:0007215) | 2.40336387 |
131 | neuromuscular process controlling balance (GO:0050885) | 2.40121313 |
132 | positive regulation of heat generation (GO:0031652) | 2.40005098 |
133 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.39995629 |
134 | regulation of vesicle fusion (GO:0031338) | 2.39691959 |
135 | membrane depolarization during action potential (GO:0086010) | 2.39413808 |
136 | synaptic vesicle endocytosis (GO:0048488) | 2.38983963 |
137 | positive regulation of dendritic spine development (GO:0060999) | 2.38795874 |
138 | long-term memory (GO:0007616) | 2.37433377 |
139 | negative regulation of interleukin-12 production (GO:0032695) | 2.37365176 |
140 | regulation of fever generation (GO:0031620) | 2.36054461 |
141 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.35187217 |
142 | positive regulation of synapse maturation (GO:0090129) | 2.34429353 |
143 | positive regulation of Rap GTPase activity (GO:0032854) | 2.32939068 |
144 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32831738 |
145 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.31435213 |
146 | acidic amino acid transport (GO:0015800) | 2.28233820 |
147 | glycolipid catabolic process (GO:0019377) | 2.27256447 |
148 | response to nerve growth factor (GO:1990089) | 2.25679121 |
149 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.25679121 |
150 | regulation of Rap GTPase activity (GO:0032317) | 2.25325195 |
151 | detection of calcium ion (GO:0005513) | 2.22445967 |
152 | response to acidic pH (GO:0010447) | 2.20057943 |
153 | cell communication involved in cardiac conduction (GO:0086065) | 2.19013404 |
154 | negative regulation of inclusion body assembly (GO:0090084) | 2.17543801 |
155 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.16997708 |
156 | regulation of neurotransmitter levels (GO:0001505) | 2.16949159 |
157 | regulation of postsynaptic membrane potential (GO:0060078) | 2.15909172 |
158 | neuromuscular process (GO:0050905) | 2.15818577 |
159 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.15193225 |
160 | barbed-end actin filament capping (GO:0051016) | 2.14980874 |
161 | alanine transport (GO:0032328) | 2.13128901 |
162 | L-glutamate transport (GO:0015813) | 2.12439075 |
163 | actin filament capping (GO:0051693) | 2.11551853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.90457988 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.46228201 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.80495749 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79707906 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.60701557 |
6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45927355 |
7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45927355 |
8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34956017 |
9 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34509254 |
10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31400161 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31394976 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.27221207 |
13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.24312284 |
14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21273131 |
15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18775308 |
16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07448574 |
17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05322540 |
18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02714521 |
19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97463791 |
20 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.92988829 |
21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.92723057 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90251727 |
23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89261070 |
24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78389531 |
25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.73568790 |
26 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67481349 |
27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67322330 |
28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67006208 |
29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65516348 |
30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62438825 |
31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60468367 |
32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59034988 |
33 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56230401 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55257856 |
35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54626784 |
36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48709179 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48455944 |
38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46228470 |
39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45739850 |
40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.45432888 |
41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43452218 |
42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41763492 |
43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40018614 |
44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39604328 |
45 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39025985 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36048975 |
47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34835549 |
48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34569614 |
49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.30139417 |
50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29748411 |
51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.29674070 |
52 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.29562052 |
53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29458654 |
54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28036288 |
55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26929004 |
56 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26597378 |
57 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25826091 |
58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24873500 |
59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24735367 |
60 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24492620 |
61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23210084 |
62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23164825 |
63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23073344 |
64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23050786 |
65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19621981 |
66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19312035 |
67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19297326 |
68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18964472 |
69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17519610 |
70 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16618618 |
71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15316262 |
72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.14905945 |
73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13958842 |
74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13583965 |
75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13576453 |
76 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10605600 |
77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09672872 |
78 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09482914 |
79 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08481828 |
80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08077999 |
81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07645343 |
82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.07211594 |
83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06582889 |
84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05835339 |
85 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05789355 |
86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05229318 |
87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04803077 |
88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04456159 |
89 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03756843 |
90 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02625835 |
91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01687482 |
92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00972418 |
93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00972418 |
94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00474719 |
95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00169436 |
96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00026360 |
97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99841404 |
98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99815894 |
99 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98646661 |
100 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98137196 |
101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97466569 |
102 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97293884 |
103 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97099393 |
104 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96961500 |
105 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96775183 |
106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96542839 |
107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96041941 |
108 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95929426 |
109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95362235 |
110 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94234185 |
111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93961310 |
112 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93610421 |
113 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93474938 |
114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93369853 |
115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93125540 |
116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92831727 |
117 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91912296 |
118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91888594 |
119 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91825884 |
120 | AR_19668381_ChIP-Seq_PC3_Human | 0.91100697 |
121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90682690 |
122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90350427 |
123 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90107611 |
124 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89685466 |
125 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89351021 |
126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89115137 |
127 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88861797 |
128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88318515 |
129 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88190094 |
130 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88119242 |
131 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88119242 |
132 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87761124 |
133 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86886370 |
134 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86462366 |
135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85177129 |
136 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84313753 |
137 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.83040729 |
138 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82920469 |
139 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.81086510 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004270_analgesia | 4.10370111 |
2 | MP0003880_abnormal_central_pattern | 4.04986484 |
3 | MP0004859_abnormal_synaptic_plasticity | 3.74038248 |
4 | MP0003303_peritoneal_inflammation | 3.52008332 |
5 | MP0000920_abnormal_myelination | 3.31130401 |
6 | MP0003635_abnormal_synaptic_transmissio | 2.84566694 |
7 | MP0002272_abnormal_nervous_system | 2.79436238 |
8 | MP0005058_abnormal_lysosome_morphology | 2.73434413 |
9 | MP0004510_myositis | 2.71102977 |
10 | MP0002734_abnormal_mechanical_nocicepti | 2.63944334 |
11 | MP0002064_seizures | 2.57854758 |
12 | MP0009046_muscle_twitch | 2.56519825 |
13 | MP0001486_abnormal_startle_reflex | 2.39692548 |
14 | MP0003329_amyloid_beta_deposits | 2.38014277 |
15 | MP0001968_abnormal_touch/_nociception | 2.35177153 |
16 | MP0009745_abnormal_behavioral_response | 2.31494450 |
17 | MP0003172_abnormal_lysosome_physiology | 2.28513534 |
18 | MP0005423_abnormal_somatic_nervous | 2.23903634 |
19 | MP0002735_abnormal_chemical_nociception | 2.23446076 |
20 | MP0006082_CNS_inflammation | 2.17332509 |
21 | MP0005167_abnormal_blood-brain_barrier | 2.15189924 |
22 | MP0003075_altered_response_to | 2.11538084 |
23 | MP0002063_abnormal_learning/memory/cond | 2.10919353 |
24 | MP0009840_abnormal_foam_cell | 2.00919721 |
25 | MP0002572_abnormal_emotion/affect_behav | 1.96120012 |
26 | MP0001970_abnormal_pain_threshold | 1.95055397 |
27 | MP0002736_abnormal_nociception_after | 1.93755310 |
28 | MP0002733_abnormal_thermal_nociception | 1.92675981 |
29 | MP0000778_abnormal_nervous_system | 1.92493708 |
30 | MP0004885_abnormal_endolymph | 1.91364971 |
31 | MP0001529_abnormal_vocalization | 1.90627750 |
32 | MP0004043_abnormal_pH_regulation | 1.88135992 |
33 | MP0004142_abnormal_muscle_tone | 1.87391890 |
34 | MP0000955_abnormal_spinal_cord | 1.80514989 |
35 | MP0003634_abnormal_glial_cell | 1.80116050 |
36 | MP0004742_abnormal_vestibular_system | 1.77093556 |
37 | MP0002067_abnormal_sensory_capabilities | 1.74281257 |
38 | MP0008569_lethality_at_weaning | 1.72811001 |
39 | MP0003950_abnormal_plasma_membrane | 1.71069766 |
40 | MP0000569_abnormal_digit_pigmentation | 1.68861083 |
41 | MP0001905_abnormal_dopamine_level | 1.66177723 |
42 | MP0002229_neurodegeneration | 1.64810934 |
43 | MP0003300_gastrointestinal_ulcer | 1.64184408 |
44 | MP0006276_abnormal_autonomic_nervous | 1.61795447 |
45 | MP0001440_abnormal_grooming_behavior | 1.60012601 |
46 | MP0003690_abnormal_glial_cell | 1.59502645 |
47 | MP0001299_abnormal_eye_distance/ | 1.57942216 |
48 | MP0000343_altered_response_to | 1.57731223 |
49 | MP0009780_abnormal_chondrocyte_physiolo | 1.56972107 |
50 | MP0005171_absent_coat_pigmentation | 1.55829741 |
51 | MP0000678_abnormal_parathyroid_gland | 1.53514900 |
52 | MP0002184_abnormal_innervation | 1.53000682 |
53 | MP0002882_abnormal_neuron_morphology | 1.52225011 |
54 | MP0001485_abnormal_pinna_reflex | 1.49966492 |
55 | MP0008004_abnormal_stomach_pH | 1.45939412 |
56 | MP0004858_abnormal_nervous_system | 1.44979055 |
57 | MP0005623_abnormal_meninges_morphology | 1.43682950 |
58 | MP0005386_behavior/neurological_phenoty | 1.41380719 |
59 | MP0004924_abnormal_behavior | 1.41380719 |
60 | MP0005166_decreased_susceptibility_to | 1.40004201 |
61 | MP0002066_abnormal_motor_capabilities/c | 1.39050396 |
62 | MP0002822_catalepsy | 1.38809998 |
63 | MP0001501_abnormal_sleep_pattern | 1.36756242 |
64 | MP0005410_abnormal_fertilization | 1.35614776 |
65 | MP0003724_increased_susceptibility_to | 1.34806747 |
66 | MP0003633_abnormal_nervous_system | 1.34322790 |
67 | MP0004811_abnormal_neuron_physiology | 1.33253305 |
68 | MP0004145_abnormal_muscle_electrophysio | 1.32910969 |
69 | MP0000462_abnormal_digestive_system | 1.30361708 |
70 | MP0003122_maternal_imprinting | 1.29677585 |
71 | MP0000013_abnormal_adipose_tissue | 1.29358325 |
72 | MP0003283_abnormal_digestive_organ | 1.28016955 |
73 | MP0003631_nervous_system_phenotype | 1.27443452 |
74 | MP0002998_abnormal_bone_remodeling | 1.24982904 |
75 | MP0005551_abnormal_eye_electrophysiolog | 1.23043217 |
76 | MP0003632_abnormal_nervous_system | 1.22933589 |
77 | MP0001348_abnormal_lacrimal_gland | 1.22307343 |
78 | MP0002557_abnormal_social/conspecific_i | 1.20212081 |
79 | MP0008874_decreased_physiological_sensi | 1.15979794 |
80 | MP0005645_abnormal_hypothalamus_physiol | 1.14168548 |
81 | MP0003436_decreased_susceptibility_to | 1.10379941 |
82 | MP0002752_abnormal_somatic_nervous | 1.08730353 |
83 | MP0002148_abnormal_hypersensitivity_rea | 1.07668993 |
84 | MP0001963_abnormal_hearing_physiology | 1.06148387 |
85 | MP0005535_abnormal_body_temperature | 1.04593352 |
86 | MP0002419_abnormal_innate_immunity | 1.02012791 |
87 | MP0005646_abnormal_pituitary_gland | 1.01345101 |
88 | MP0002909_abnormal_adrenal_gland | 1.01126700 |
89 | MP0001502_abnormal_circadian_rhythm | 1.00738482 |
90 | MP0005409_darkened_coat_color | 0.97945626 |
91 | MP0000604_amyloidosis | 0.96869128 |
92 | MP0002152_abnormal_brain_morphology | 0.96056652 |
93 | MP0000747_muscle_weakness | 0.95347390 |
94 | MP0003448_altered_tumor_morphology | 0.94505636 |
95 | MP0009785_altered_susceptibility_to | 0.93768880 |
96 | MP0010386_abnormal_urinary_bladder | 0.93226561 |
97 | MP0001984_abnormal_olfaction | 0.92431639 |
98 | MP0003091_abnormal_cell_migration | 0.91719891 |
99 | MP0002896_abnormal_bone_mineralization | 0.91557824 |
100 | MP0001533_abnormal_skeleton_physiology | 0.90858396 |
101 | MP0006072_abnormal_retinal_apoptosis | 0.90262035 |
102 | MP0002877_abnormal_melanocyte_morpholog | 0.90168264 |
103 | MP0003191_abnormal_cellular_cholesterol | 0.88380832 |
104 | MP0001177_atelectasis | 0.87622245 |
105 | MP0004134_abnormal_chest_morphology | 0.85535861 |
106 | MP0009278_abnormal_bone_marrow | 0.84221097 |
107 | MP0005595_abnormal_vascular_smooth | 0.83469167 |
108 | MP0001986_abnormal_taste_sensitivity | 0.83117757 |
109 | MP0008438_abnormal_cutaneous_collagen | 0.82607640 |
110 | MP0000003_abnormal_adipose_tissue | 0.80893277 |
111 | MP0009764_decreased_sensitivity_to | 0.80843415 |
112 | MP0000751_myopathy | 0.80242720 |
113 | MP0003879_abnormal_hair_cell | 0.79964467 |
114 | MP0001958_emphysema | 0.76721456 |
115 | MP0006054_spinal_hemorrhage | 0.76496828 |
116 | MP0003183_abnormal_peptide_metabolism | 0.76144073 |
117 | MP0003195_calcinosis | 0.75431093 |
118 | MP0005310_abnormal_salivary_gland | 0.75354100 |
119 | MP0003279_aneurysm | 0.75276863 |
120 | MP0004085_abnormal_heartbeat | 0.74799680 |
121 | MP0001346_abnormal_lacrimal_gland | 0.74268833 |
122 | MP0003705_abnormal_hypodermis_morpholog | 0.73304505 |
123 | MP0002837_dystrophic_cardiac_calcinosis | 0.72794957 |
124 | MP0005000_abnormal_immune_tolerance | 0.71770701 |
125 | MP0000631_abnormal_neuroendocrine_gland | 0.71000829 |
126 | MP0003787_abnormal_imprinting | 0.70750328 |
127 | MP0004147_increased_porphyrin_level | 0.70734260 |
128 | MP0004036_abnormal_muscle_relaxation | 0.70677861 |
129 | MP0010234_abnormal_vibrissa_follicle | 0.69663805 |
130 | MP0002751_abnormal_autonomic_nervous | 0.68719740 |
131 | MP0002090_abnormal_vision | 0.68612745 |
132 | MP0002139_abnormal_hepatobiliary_system | 0.68182425 |
133 | MP0001664_abnormal_digestion | 0.67917010 |
134 | MP0003045_fibrosis | 0.67686802 |
135 | MP0005253_abnormal_eye_physiology | 0.67187677 |
136 | MP0003136_yellow_coat_color | 0.65954837 |
137 | MP0002069_abnormal_eating/drinking_beha | 0.65292284 |
138 | MP0000534_abnormal_ureter_morphology | 0.64750582 |
139 | MP0000026_abnormal_inner_ear | 0.64364336 |
140 | MP0002971_abnormal_brown_adipose | 0.64303941 |
141 | MP0003137_abnormal_impulse_conducting | 0.63650327 |
142 | MP0001943_abnormal_respiration | 0.63308096 |
143 | MP0001188_hyperpigmentation | 0.62995241 |
144 | MP0005025_abnormal_response_to | 0.62149464 |
145 | MP0004484_altered_response_of | 0.61869852 |
146 | MP0008260_abnormal_autophagy | 0.61586448 |
147 | MP0001765_abnormal_ion_homeostasis | 0.58733998 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.98036718 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.98036718 |
3 | Myokymia (HP:0002411) | 4.95735660 |
4 | Neurofibrillary tangles (HP:0002185) | 4.77114991 |
5 | Mutism (HP:0002300) | 4.65317572 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.64224017 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.64224017 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.64224017 |
9 | Supranuclear gaze palsy (HP:0000605) | 4.41575899 |
10 | Abnormality of the corticospinal tract (HP:0002492) | 4.23974475 |
11 | Termporal pattern (HP:0011008) | 4.12321190 |
12 | Insidious onset (HP:0003587) | 4.12321190 |
13 | Focal motor seizures (HP:0011153) | 3.87388629 |
14 | Ankle clonus (HP:0011448) | 3.82039839 |
15 | Peripheral hypomyelination (HP:0007182) | 3.72699176 |
16 | Cerebral inclusion bodies (HP:0100314) | 3.65132293 |
17 | Pheochromocytoma (HP:0002666) | 3.61324964 |
18 | Action tremor (HP:0002345) | 3.56474457 |
19 | Onion bulb formation (HP:0003383) | 3.56448038 |
20 | Spastic gait (HP:0002064) | 3.55670726 |
21 | Disinhibition (HP:0000734) | 3.43001165 |
22 | Apathy (HP:0000741) | 3.33856979 |
23 | Atonic seizures (HP:0010819) | 3.29873886 |
24 | Increased cerebral lipofuscin (HP:0011813) | 3.21889269 |
25 | Vacuolated lymphocytes (HP:0001922) | 3.18752933 |
26 | Dysmetria (HP:0001310) | 3.17383477 |
27 | Focal seizures (HP:0007359) | 3.16530739 |
28 | Dysostosis multiplex (HP:0000943) | 3.15440152 |
29 | Neuroendocrine neoplasm (HP:0100634) | 3.08852149 |
30 | Diminished motivation (HP:0000745) | 3.06577299 |
31 | Diplopia (HP:0000651) | 3.02625314 |
32 | Abnormality of binocular vision (HP:0011514) | 3.02625314 |
33 | Scanning speech (HP:0002168) | 3.00336037 |
34 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.96662208 |
35 | Ulnar claw (HP:0001178) | 2.86689359 |
36 | Sensory axonal neuropathy (HP:0003390) | 2.85309244 |
37 | Loss of speech (HP:0002371) | 2.83158613 |
38 | Retinal dysplasia (HP:0007973) | 2.82979697 |
39 | Epileptic encephalopathy (HP:0200134) | 2.80463075 |
40 | Intention tremor (HP:0002080) | 2.79612685 |
41 | Systemic lupus erythematosus (HP:0002725) | 2.76534749 |
42 | Inappropriate behavior (HP:0000719) | 2.74389111 |
43 | Progressive cerebellar ataxia (HP:0002073) | 2.72558557 |
44 | Cerebral hypomyelination (HP:0006808) | 2.71092306 |
45 | Nuclear cataract (HP:0100018) | 2.68081392 |
46 | Abnormal auditory evoked potentials (HP:0006958) | 2.64948282 |
47 | Alacrima (HP:0000522) | 2.55406330 |
48 | Hammertoe (HP:0001765) | 2.54801719 |
49 | Lower limb muscle weakness (HP:0007340) | 2.54469266 |
50 | Foot dorsiflexor weakness (HP:0009027) | 2.53868196 |
51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49772613 |
52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49772613 |
53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49772613 |
54 | Mucopolysacchariduria (HP:0008155) | 2.46036652 |
55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46036652 |
56 | Abnormality of macrophages (HP:0004311) | 2.45566817 |
57 | Decreased motor nerve conduction velocity (HP:0003431) | 2.44922763 |
58 | Hemiplegia (HP:0002301) | 2.43992557 |
59 | Axonal loss (HP:0003447) | 2.42966618 |
60 | Truncal ataxia (HP:0002078) | 2.41364460 |
61 | Urinary urgency (HP:0000012) | 2.40754688 |
62 | Megalencephaly (HP:0001355) | 2.39711808 |
63 | Amyloidosis (HP:0011034) | 2.38422002 |
64 | Dementia (HP:0000726) | 2.37831740 |
65 | Absence seizures (HP:0002121) | 2.34757453 |
66 | Abnormality of the foot musculature (HP:0001436) | 2.34071315 |
67 | Visual hallucinations (HP:0002367) | 2.33304904 |
68 | Dialeptic seizures (HP:0011146) | 2.30169035 |
69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29265149 |
70 | Rapidly progressive (HP:0003678) | 2.27978943 |
71 | Abnormality of the periventricular white matter (HP:0002518) | 2.27516901 |
72 | Slow saccadic eye movements (HP:0000514) | 2.27385529 |
73 | Clonus (HP:0002169) | 2.24584845 |
74 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.23661106 |
75 | Tetraplegia (HP:0002445) | 2.22427883 |
76 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.21478012 |
77 | Hyperphosphatemia (HP:0002905) | 2.18054758 |
78 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.16951238 |
79 | Aplasia of the phalanges of the hand (HP:0009802) | 2.16951238 |
80 | Aplasia involving bones of the extremities (HP:0009825) | 2.16951238 |
81 | Steppage gait (HP:0003376) | 2.15737831 |
82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.14181172 |
83 | Generalized tonic-clonic seizures (HP:0002069) | 2.13314090 |
84 | Dysdiadochokinesis (HP:0002075) | 2.12662708 |
85 | Eczematoid dermatitis (HP:0000976) | 2.11800794 |
86 | Hematochezia (HP:0002573) | 2.11130484 |
87 | Tetany (HP:0001281) | 2.10954897 |
88 | Thickened helices (HP:0000391) | 2.10925047 |
89 | Akinesia (HP:0002304) | 2.10466976 |
90 | Distal sensory impairment (HP:0002936) | 2.10127042 |
91 | Anteriorly placed anus (HP:0001545) | 2.10082659 |
92 | Memory impairment (HP:0002354) | 2.09537867 |
93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08589140 |
94 | Febrile seizures (HP:0002373) | 2.07814249 |
95 | Obstructive sleep apnea (HP:0002870) | 2.07438686 |
96 | Hyperparathyroidism (HP:0000843) | 2.06906406 |
97 | Recurrent bacterial skin infections (HP:0005406) | 2.06325663 |
98 | Anxiety (HP:0000739) | 2.05984819 |
99 | Increased circulating renin level (HP:0000848) | 2.04827258 |
100 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.04628883 |
101 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03462911 |
102 | Retinal atrophy (HP:0001105) | 2.03277927 |
103 | Polyphagia (HP:0002591) | 2.02093214 |
104 | Limb dystonia (HP:0002451) | 2.00671734 |
105 | Rigidity (HP:0002063) | 1.99860809 |
106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98298155 |
107 | Decreased lacrimation (HP:0000633) | 1.97889499 |
108 | Bradykinesia (HP:0002067) | 1.97873872 |
109 | Cerebral aneurysm (HP:0004944) | 1.96902272 |
110 | Gaze-evoked nystagmus (HP:0000640) | 1.95768582 |
111 | Focal dystonia (HP:0004373) | 1.94202347 |
112 | Papilledema (HP:0001085) | 1.93968089 |
113 | Depression (HP:0000716) | 1.93708943 |
114 | Agnosia (HP:0010524) | 1.93392901 |
115 | Bundle branch block (HP:0011710) | 1.93360860 |
116 | CNS hypomyelination (HP:0003429) | 1.91385924 |
117 | Asymmetric septal hypertrophy (HP:0001670) | 1.89445000 |
118 | Autoamputation (HP:0001218) | 1.89351898 |
119 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.87780300 |
120 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.86328062 |
121 | Ventricular fibrillation (HP:0001663) | 1.83903040 |
122 | Buphthalmos (HP:0000557) | 1.83818252 |
123 | Vaginal atresia (HP:0000148) | 1.83291648 |
124 | Postural tremor (HP:0002174) | 1.82710529 |
125 | Craniofacial dystonia (HP:0012179) | 1.82149136 |
126 | Glomerulonephritis (HP:0000099) | 1.81854753 |
127 | Parakeratosis (HP:0001036) | 1.80759039 |
128 | Genital tract atresia (HP:0001827) | 1.80239949 |
129 | Cerebral hemorrhage (HP:0001342) | 1.79218483 |
130 | Leukodystrophy (HP:0002415) | 1.78860324 |
131 | Recurrent abscess formation (HP:0002722) | 1.78782187 |
132 | Resting tremor (HP:0002322) | 1.78303046 |
133 | Abnormal eating behavior (HP:0100738) | 1.77052169 |
134 | Poor speech (HP:0002465) | 1.76684446 |
135 | Postural instability (HP:0002172) | 1.76071756 |
136 | Neuronal loss in central nervous system (HP:0002529) | 1.75946791 |
137 | Metabolic alkalosis (HP:0200114) | 1.75204208 |
138 | Urinary incontinence (HP:0000020) | 1.74751004 |
139 | Torticollis (HP:0000473) | 1.73887079 |
140 | Type II lissencephaly (HP:0007260) | 1.73578360 |
141 | Infantile muscular hypotonia (HP:0008947) | 1.73337203 |
142 | Agitation (HP:0000713) | 1.72307162 |
143 | Increased CSF protein (HP:0002922) | 1.72030133 |
144 | Hyporeflexia of lower limbs (HP:0002600) | 1.71935592 |
145 | Broad-based gait (HP:0002136) | 1.71801148 |
146 | Hemiparesis (HP:0001269) | 1.71504334 |
147 | Bradycardia (HP:0001662) | 1.71480491 |
148 | Split foot (HP:0001839) | 1.70233180 |
149 | Spontaneous hematomas (HP:0007420) | 1.70182173 |
150 | Stereotypic behavior (HP:0000733) | 1.69811311 |
151 | Metaphyseal irregularity (HP:0003025) | 1.69475814 |
152 | Slow progression (HP:0003677) | 1.69214725 |
153 | EEG with generalized epileptiform discharges (HP:0011198) | 1.69066618 |
154 | Abnormality of saccadic eye movements (HP:0000570) | 1.68335527 |
155 | Spastic tetraparesis (HP:0001285) | 1.68142909 |
156 | Personality changes (HP:0000751) | 1.66869104 |
157 | Epileptiform EEG discharges (HP:0011182) | 1.66804399 |
158 | Clumsiness (HP:0002312) | 1.66437455 |
159 | Paraplegia (HP:0010550) | 1.66395584 |
160 | Stridor (HP:0010307) | 1.66353518 |
161 | Spastic paraplegia (HP:0001258) | 1.66151618 |
162 | Progressive inability to walk (HP:0002505) | 1.63955816 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 4.57458683 |
2 | OXSR1 | 3.10014753 |
3 | RIPK1 | 2.98388728 |
4 | NTRK1 | 2.65682430 |
5 | NTRK3 | 2.61704375 |
6 | WNK1 | 2.40013853 |
7 | WNK4 | 2.36634389 |
8 | LIMK1 | 2.31241632 |
9 | MAP3K9 | 2.08804661 |
10 | PAK6 | 2.02410103 |
11 | RIPK4 | 2.01942836 |
12 | MAPKAPK5 | 2.01647033 |
13 | UHMK1 | 1.98975627 |
14 | BCR | 1.92653411 |
15 | MARK1 | 1.92054839 |
16 | MINK1 | 1.88775969 |
17 | CDK19 | 1.87640164 |
18 | IRAK3 | 1.83595168 |
19 | EPHB1 | 1.83592996 |
20 | PNCK | 1.79100577 |
21 | EPHA4 | 1.70702600 |
22 | MAP3K4 | 1.70488991 |
23 | PKN1 | 1.68605960 |
24 | PRKD3 | 1.66048562 |
25 | PRPF4B | 1.63798155 |
26 | CASK | 1.55011069 |
27 | KSR2 | 1.54425300 |
28 | MOS | 1.50811800 |
29 | GRK7 | 1.49750717 |
30 | SGK494 | 1.48178178 |
31 | SGK223 | 1.48178178 |
32 | CAMK2B | 1.42746253 |
33 | MET | 1.37319988 |
34 | FGFR2 | 1.35443425 |
35 | PAK3 | 1.34816842 |
36 | CDK5 | 1.29245842 |
37 | ARAF | 1.28353410 |
38 | TGFBR2 | 1.26906707 |
39 | CAMK2D | 1.26813074 |
40 | NEK6 | 1.23898342 |
41 | CSNK1A1L | 1.22612684 |
42 | MAP3K2 | 1.22007806 |
43 | CSNK1G3 | 1.20327364 |
44 | ROCK2 | 1.19357633 |
45 | ACVR1B | 1.18770469 |
46 | LMTK2 | 1.17801675 |
47 | PHKG1 | 1.17257524 |
48 | PHKG2 | 1.17257524 |
49 | TESK2 | 1.16840858 |
50 | CSNK1G2 | 1.16091273 |
51 | MAP2K7 | 1.15620714 |
52 | NTRK2 | 1.13430093 |
53 | SIK2 | 1.09222977 |
54 | BLK | 1.08782494 |
55 | CDK14 | 1.08746973 |
56 | TNIK | 1.07595287 |
57 | BMPR2 | 1.06553258 |
58 | MAP3K11 | 1.04946682 |
59 | CAMK2A | 1.04537563 |
60 | CAMK2G | 1.03017298 |
61 | CDK15 | 0.97832684 |
62 | PDGFRA | 0.96780911 |
63 | CDK18 | 0.95909184 |
64 | MAP3K14 | 0.95087779 |
65 | MATK | 0.93840539 |
66 | ICK | 0.92322825 |
67 | MARK2 | 0.91832719 |
68 | STK38 | 0.91411833 |
69 | MAPK13 | 0.90173671 |
70 | CAMK1 | 0.89803305 |
71 | SGK3 | 0.89756634 |
72 | SGK2 | 0.89434768 |
73 | CAMK1D | 0.87399468 |
74 | PBK | 0.87155435 |
75 | JAK1 | 0.86759409 |
76 | CDK11A | 0.85548277 |
77 | LATS2 | 0.85297213 |
78 | PRKCH | 0.83627015 |
79 | PRKCE | 0.81163477 |
80 | MAP3K3 | 0.80727309 |
81 | FES | 0.80488963 |
82 | CSNK1G1 | 0.79904668 |
83 | DDR2 | 0.79865303 |
84 | TYRO3 | 0.76743864 |
85 | GRK5 | 0.76022037 |
86 | PLK2 | 0.75823931 |
87 | TAOK1 | 0.74986491 |
88 | TAOK2 | 0.74313845 |
89 | MAPK15 | 0.73638411 |
90 | MAPK12 | 0.72594488 |
91 | JAK2 | 0.72418091 |
92 | RET | 0.71523163 |
93 | MAP2K4 | 0.70724297 |
94 | PRKD1 | 0.69733025 |
95 | CSK | 0.69280595 |
96 | CAMKK2 | 0.67281766 |
97 | PDPK1 | 0.66902055 |
98 | TYK2 | 0.66162039 |
99 | CAMK4 | 0.65991132 |
100 | CAMKK1 | 0.65822598 |
101 | FGR | 0.65326051 |
102 | PRKCG | 0.63844910 |
103 | ALK | 0.62653189 |
104 | TESK1 | 0.62428979 |
105 | DAPK2 | 0.60442209 |
106 | CDC42BPA | 0.58798052 |
107 | FER | 0.56129874 |
108 | STK11 | 0.55475780 |
109 | DYRK1A | 0.54668363 |
110 | DYRK2 | 0.54469075 |
111 | MAP3K13 | 0.54263368 |
112 | PINK1 | 0.53551381 |
113 | MAP3K1 | 0.53321971 |
114 | CAMK1G | 0.52610306 |
115 | HIPK2 | 0.52067228 |
116 | DAPK1 | 0.51609394 |
117 | PRKG1 | 0.49982830 |
118 | IRAK2 | 0.49547349 |
119 | BMPR1B | 0.49272469 |
120 | RPS6KA2 | 0.47872819 |
121 | FYN | 0.47546063 |
122 | INSRR | 0.47021575 |
123 | ABL2 | 0.46791103 |
124 | PDGFRB | 0.46584766 |
125 | MAPK10 | 0.46333710 |
126 | PTK2B | 0.44956055 |
127 | MUSK | 0.44036507 |
128 | MAPK7 | 0.43798495 |
129 | PRKCZ | 0.42804267 |
130 | PRKACB | 0.42760426 |
131 | BRAF | 0.42674635 |
132 | PRKCQ | 0.41888415 |
133 | CLK1 | 0.41552358 |
134 | KSR1 | 0.41361392 |
135 | PRKG2 | 0.40732692 |
136 | PTK2 | 0.40599471 |
137 | ROCK1 | 0.40498351 |
138 | MAPK4 | 0.39328261 |
139 | PKN2 | 0.38416524 |
140 | SGK1 | 0.37480680 |
141 | WNK3 | 0.36891300 |
142 | PDK1 | 0.36799242 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.87586013 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.56080705 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27155752 |
4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.16392756 |
5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.04145301 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.01340061 |
7 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.00863281 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00633846 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99324292 |
10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.99286138 |
11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.93552217 |
12 | Morphine addiction_Homo sapiens_hsa05032 | 1.87971454 |
13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.86166641 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 1.80845575 |
15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.77585936 |
16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72360486 |
17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71405655 |
18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.70893061 |
19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.69793281 |
20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.66454847 |
21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.60029860 |
22 | Taste transduction_Homo sapiens_hsa04742 | 1.59085151 |
23 | Salivary secretion_Homo sapiens_hsa04970 | 1.58763873 |
24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57858867 |
25 | Long-term depression_Homo sapiens_hsa04730 | 1.55989701 |
26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.53567992 |
27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52876624 |
28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.51851652 |
29 | Axon guidance_Homo sapiens_hsa04360 | 1.51322220 |
30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48616077 |
31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.45881764 |
32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43075155 |
33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33022468 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32751891 |
35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32047299 |
36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28250775 |
37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25871966 |
38 | Renin secretion_Homo sapiens_hsa04924 | 1.24425271 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23537901 |
40 | Gap junction_Homo sapiens_hsa04540 | 1.20199347 |
41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.19077243 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.17734887 |
43 | Tuberculosis_Homo sapiens_hsa05152 | 1.16664825 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14042025 |
45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13414872 |
46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12362385 |
47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.10477135 |
48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07355537 |
49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06527761 |
50 | Salmonella infection_Homo sapiens_hsa05132 | 1.05856512 |
51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05787326 |
52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04920437 |
53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04913467 |
54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02853913 |
55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02580421 |
56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.98871334 |
57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98838657 |
58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98776121 |
59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98752112 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97537080 |
61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.96806281 |
62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94448792 |
63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93810336 |
64 | Phototransduction_Homo sapiens_hsa04744 | 0.93591351 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.93497406 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91063182 |
67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90833268 |
68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90116375 |
69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89618319 |
70 | Protein export_Homo sapiens_hsa03060 | 0.87404304 |
71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87331487 |
72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87041412 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.86615331 |
74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86128556 |
75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86091669 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85732237 |
77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85367083 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85220020 |
79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83602951 |
80 | Malaria_Homo sapiens_hsa05144 | 0.82846980 |
81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82498561 |
82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82191217 |
83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81501258 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80887858 |
85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80864593 |
86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80066457 |
87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79319497 |
88 | Melanogenesis_Homo sapiens_hsa04916 | 0.79047971 |
89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78941764 |
90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77239770 |
91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76995545 |
92 | Endocytosis_Homo sapiens_hsa04144 | 0.76886141 |
93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75890407 |
94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74193341 |
95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73683376 |
96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73327511 |
97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73245593 |
98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72907065 |
99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72573380 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72366760 |
101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70759801 |
102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70273620 |
103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69019836 |
104 | * Tight junction_Homo sapiens_hsa04530 | 0.68976129 |
105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68125523 |
106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68003491 |
107 | Legionellosis_Homo sapiens_hsa05134 | 0.66980268 |
108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66818760 |
109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64923372 |
110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64055216 |
111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61584938 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59939348 |
113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59669844 |
114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58752473 |
115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57650620 |
116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57539063 |
117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57393901 |
118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55400629 |
119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55361836 |
120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54777772 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54529381 |
122 | Glioma_Homo sapiens_hsa05214 | 0.54127231 |
123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52527103 |
124 | Bile secretion_Homo sapiens_hsa04976 | 0.52342299 |
125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51942771 |
126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51525926 |
127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50908687 |
128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50849443 |
129 | Platelet activation_Homo sapiens_hsa04611 | 0.50773568 |
130 | Alcoholism_Homo sapiens_hsa05034 | 0.50461975 |
131 | Prion diseases_Homo sapiens_hsa05020 | 0.48740988 |
132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47334890 |
133 | Phagosome_Homo sapiens_hsa04145 | 0.46745707 |
134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46731837 |
135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44411002 |
136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43197517 |
137 | Lysosome_Homo sapiens_hsa04142 | 0.43130982 |
138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42087829 |